Cancer Biomarkers—Detection and Evaluation of Response to Therapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Biomarkers".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 87
Special Issue Editors
Interests: chemotherapy; cancer biology; metronomic chemotherapy; metastasis; immunotherapy
Special Issue Information
Dear Colleagues,
Cancer biomarkers are increasingly important in the detection of earlier stages of disease; they are essential, and still in need of discovery, in the optimal dosing of anti-cancer drugs, predicting treatment-related toxicity, and selecting therapies that can most benefit either individual patients or subgroups with a particular cancer.
This Special issue will explore past and present biomarkers, novel biomarkers, and the use of biomarkers with different diagnostic and treatment options to improve the detection and management of cancer.
Dr. Giulio Francia
Dr. Jianying Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- cancer detection
- biomarkers of response to antineoplastic drugs
- biomarkers of resistance to chemotherapy
- biomarkers for targeted therapies
